Guerbet (XPAR:GBT) Marketable Securities : €41.5 Mil (As of Dec. 2023)

View and export this data going back to 1989. Start your Free Trial

What is Guerbet Marketable Securities?

Marketable Securities are very liquid securities that can be converted into cash quickly at a reasonable price. Guerbet's Marketable Securities for the quarter that ended in Dec. 2023 was €41.5 Mil.

Guerbet's annual Marketable Securities declined from Dec. 2021 (€42.9 Mil) to Dec. 2022 (€41.2 Mil) but then increased from Dec. 2022 (€41.2 Mil) to Dec. 2023 (€41.5 Mil).

Guerbet Marketable Securities Historical Data

The historical data trend for Guerbet's Marketable Securities can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Guerbet Marketable Securities Chart

Guerbet Annual Data

Trend

Dec14

Dec15

Dec16

Dec17

Dec18

Dec19

Dec20

Dec21

Dec22

Dec23

Marketable Securities

Get a 7-Day Free Trial

36.04

33.15

42.90

41.17

41.48

Guerbet Semi-Annual Data
	Jun14	Dec14	Jun15	Dec15	Jun16	Dec16	Jun17	Dec17	Jun18	Dec18	Jun19	Dec19	Jun20	Dec20	Jun21	Dec21	Jun22	Dec22	Jun23	Dec23
Marketable Securities	Get a 7-Day Free Trial															42.90	63.93	41.17	72.27	41.48

Guerbet Marketable Securities Calculation

Marketable Securities are very liquid securities that can be converted into cash quickly at a reasonable price.

Guerbet (XPAR:GBT) Marketable Securities Explanation

Marketable Securities are very liquid as they tend to have maturities of less than one year. Furthermore, the rate at which these securities can be bought or sold has little effect on their prices.

Please note, GuruFocus' Marketable Securities also includes "Other Short Term Investment".

Guerbet Marketable Securities Related Terms

Thank you for viewing the detailed overview of Guerbet's Marketable Securities provided by GuruFocus.com. Please click on the following links to see related term pages.

Guerbet (XPAR:GBT) Business Description

Industry

GURUFOCUS.COM » STOCK LIST » Healthcare » Medical Devices & Instruments » Guerbet SA (XPAR:GBT) » Definitions » Marketable Securities

Comparable Companies

Traded in Other Exchanges

4G8:Germany

Address

15 rue des Vanesses, Zone Paris Nord II, Villepinte, FRA, 93420

Website

http://www.guerbet.com

Guerbet SA is a healthcare company that manufactures and markets medical imaging contrast agents destined for diagnostic purposes. Its products include medical imaging contrast products for x-ray imaging, magnetic resonance imaging, ultrasound imaging and for nuclear medicine. The company markets its products under the brand names such as Xenetix, Optiray, Oxilan, Telebrix, Lipiodol, Dotarem, Endorem, Artirem, Lumirem, and Lipiodol.